While this may be one reason why differences in labeling were observed across PDAC models evaluated in this study, additional factors such as tumor initiation and growth rates, cells of origin, p53 status, and different composition of cancer and stromal cells are known to exist as well (Rosenfeldt et al., 2013; Vennin et al., 2019). The gene discussed is TP53; the disease is cancer.